Discussion of ISCP 2017 - Prevention and Treatment of atherosclerosis

↳ This is a section part of Moment: ISCP 2017 - Prevention and Treatment of Atherosclerosis

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Discussion of Prevention and Treatment of atherosclerosis at ISCP 2017.

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Cardiologists, interventional Cardiologists
  • Interventional Fellows
  • Interventional Radiologists
  • Vascular Surgeons
  • Emergency Physicians

Learning Objectives

Other Components in this Moment

Overview
Lipid Lowering with Statins and Ezetimibe: The Role in 2017 - Álvaro Sosa Liprandi
Clinical Data with PCSK9 inhibitors - Alberto Lorenzatti
The Paradox of Smoking and Obesity During the Prevention of Atherosclerosis - Koji Hasegawa
Modulating Cardiovascular Risk with Antidiabetic therapy: The Big Surprise and Lessons for the Future - José Ramón González Juanatey
Refractory Hypertension: What is Essential to Know in 2017 - Thomas Kahan
Myocardial infarction and Non-Obstructive Coronary Arteries - Stefan Agewall
Discussion of ISCP 2017 - Prevention and Treatment of atherosclerosis
Loading Simple Education